The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Summarize the etiology and pathogenesis of C. Difficile infections
Distinguish among selective pharmaceutical agents that predispose patients to C. Difficile colitis
Define the unique risk factors for patients with inflammatory bowel disease and C. Difficile infections and their treatment challenges
Speaker(s):
Deborah
A. Andris,
MSN, APNP,
Nurse Practitioner,
Division of Colorectal Surgery, Medical College of Wisconsin, Milwaukee, WI
Todd
Canada,
PharmD, BCNSP, BCCCP, FASHP, FTSHP,
Nutrition Support Team Coordinator,
University of Texas MD Anderson Cancer Center, Division of Pharmacy, Houston, TX